Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 5, 2002
[Diagnosis and treatment of oral precancerous lesions]
J Sudbø, T Warloe, S Aamdal, et al.
Journal of Experimental Therapeutics & Oncology
|
May 1, 1996
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
K A Semb, S Aamdal, S D Fosså, et al.
Melanoma Research
|
January 26, 1999
Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma
K A Semb, S Aamdal, T Bohmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 25, 2000
Immunobead-based detection and characterization of circulating tumor cells in melanoma patients
O Fodstad, R Faye, H K Høifødt, et al.
International Journal of Cancer
|
March 15, 1988
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
O Fodstad, S Aamdal, M McMenamin, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)
S Aamdal, B Lund, I Koier, et al.
The American Journal of Pathology
|
September 1, 1992
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods
K Beiske, A T Myklebust, S Aamdal, et al.
Anti-Cancer Drugs
|
December 5, 1998
Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanoma
K A Semb, S Aamdal, E Mette, et al.
Anti-Cancer Drugs
|
March 1, 1997
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation
K A Semb, O Fodstad, B Klem, et al.
The British Journal of Cancer. Supplement
|
June 1, 1991
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
A T Myklebust, K Beiske, A Pharo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 5, 2002
[Diagnosis and treatment of oral precancerous lesions]
J Sudbø, T Warloe, S Aamdal, et al.
Journal of Experimental Therapeutics & Oncology
|
May 1, 1996
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
K A Semb, S Aamdal, S D Fosså, et al.
Melanoma Research
|
January 26, 1999
Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma
K A Semb, S Aamdal, T Bohmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
November 25, 2000
Immunobead-based detection and characterization of circulating tumor cells in melanoma patients
O Fodstad, R Faye, H K Høifødt, et al.
International Journal of Cancer
|
March 15, 1988
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
O Fodstad, S Aamdal, M McMenamin, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Phase I trial with weekly EO9, a novel bioreductive alkylating indoloquinone, by the EORTC Early Clinical Study Group (ECSG)
S Aamdal, B Lund, I Koier, et al.
The American Journal of Pathology
|
September 1, 1992
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods
K Beiske, A T Myklebust, S Aamdal, et al.
Anti-Cancer Drugs
|
December 5, 1998
Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanoma
K A Semb, S Aamdal, E Mette, et al.
Anti-Cancer Drugs
|
March 1, 1997
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation
K A Semb, O Fodstad, B Klem, et al.
The British Journal of Cancer. Supplement
|
June 1, 1991
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
A T Myklebust, K Beiske, A Pharo, et al.
Page
of 7